This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ecarot, B. Articles by Desbarats, M. Search for Related Content PubMed PubMed Citation Articles by Ecarot, B. Articles by Desbarats, M.

1,25-(OH)₂D₃ Down-Regulates Expression of Phex, a Marker of the Mature Osteoblast¹

Genetics Unit, Shriners Hospital, Departments of Surgery and Human Genetics, McGill University, Montréal, Québec H3G 1A6, Canada

Address all correspondence and requests for reprints to: B. Ecarot, Genetics Unit, Shriners Hospital for Children, 1529 Cedar Avenue, Montréal, Québec H3G 1A6, Canada. E-mail: becarot{at}shriners.mcgill.ca

Mutations in the PHEX/Phex gene, which encodes for a protein with homology to neutral endopeptidases, are responsible for human and murine X-linked hypophosphatemia. The present study examined Phex messenger RNA (mRNA) and protein expression in cultured osteoblasts and its regulation by 1,25-(OH)₂D₃. Phex mRNA levels were quantitated on Northern blots by densitometric analysis relatively to GAPDH mRNA levels. Immunoreactive Phex protein levels were evaluated by immunoprecipitation using a polyclonal rabbit antiserum raised against a mouse Phex carboxy-terminal peptide.

ß-Glycerophosphate-induced matrix mineralization in primary osteoblast cultures was associated with significant increases in Phex mRNA and protein. Phex mRNA and protein levels were low or undetectable in proliferating preosteoblastic MC3T3-E1 cells and dramatically increased concomitantly with initiation of matrix mineralization. The pattern of Phex expression, however, was similar in nonmineralizing cultures grown in the absence of ß-glycerophosphate, indicating that the induction of Phex expression in MC3T3-E1 cells was related to cell differentiation rather than matrix mineralization. 1,25-(OH)₂D₃ inhibited mineral deposition and down-regulated Phex mRNA and protein expression in a time- and dose-dependent manner.

These results indicate that Phex is a marker of the fully differentiated osteoblast and that its expression is stimulated during ß-glycerophosphate-induced mineralization in primary osteoblast cultures and down-regulated by 1,25-(OH)₂D₃, an inhibitor of matrix mineralization. These findings add support for Phex having an important role in bone mineralization.

This article has been cited by other articles:

				S. Liu, W. Tang, J. Zhou, J. R. Stubbs, Q. Luo, M. Pi, and L. D. Quarles Fibroblast Growth Factor 23 Is a Counter-Regulatory Phosphaturic Hormone for Vitamin D J. Am. Soc. Nephrol., May 1, 2006; 17(5): 1305 - 1315. [Abstract] [Full Text] [PDF]

				H. Saito, A. Maeda, S.-i. Ohtomo, M. Hirata, K. Kusano, S. Kato, E. Ogata, H. Segawa, K.-i. Miyamoto, and N. Fukushima Circulating FGF-23 Is Regulated by 1{alpha},25-Dihydroxyvitamin D3 and Phosphorus in Vivo J. Biol. Chem., January 28, 2005; 280(4): 2543 - 2549. [Abstract] [Full Text] [PDF]

				E. R. Hines, O. I. Kolek, M. D. Jones, S. H. Serey, N. B. Sirjani, P. R. Kiela, P. W. Jurutka, M. R. Haussler, J. F. Collins, and F. K. Ghishan 1,25-Dihydroxyvitamin D3 Down-regulation of PHEX Gene Expression Is Mediated by Apparent Repression of a 110 kDa Transfactor That Binds to a Polyadenine Element in the Promoter J. Biol. Chem., November 5, 2004; 279(45): 46406 - 46414. [Abstract] [Full Text] [PDF]

				P. S.N. Rowe THE WRICKKENED PATHWAYS OF FGF23, MEPE AND PHEX Crit. Rev. Oral. Biol. Med., September 1, 2004; 15(5): 264 - 281. [Abstract] [Full Text] [PDF]

				T. Larsson, R. Marsell, E. Schipani, C. Ohlsson, O. Ljunggren, H. S. Tenenhouse, H. Juppner, and K. B. Jonsson Transgenic Mice Expressing Fibroblast Growth Factor 23 under the Control of the {alpha}1(I) Collagen Promoter Exhibit Growth Retardation, Osteomalacia, and Disturbed Phosphate Homeostasis Endocrinology, July 1, 2004; 145(7): 3087 - 3094. [Abstract] [Full Text] [PDF]

				A. J. Brewer, L. Canaff, G. N. Hendy, and H. S. Tenenhouse Differential regulation of PHEX expression in bone and parathyroid gland by chronic renal insufficiency and 1,25-dihydroxyvitamin D3 Am J Physiol Renal Physiol, April 1, 2004; 286(4): F739 - F748. [Abstract] [Full Text] [PDF]

				G. Valverde-Franco, H. Liu, D. Davidson, S. Chai, H. Valderrama-Carvajal, D. Goltzman, D. M. Ornitz, and J. E. Henderson Defective bone mineralization and osteopenia in young adult FGFR3-/- mice Hum. Mol. Genet., February 1, 2004; 13(3): 271 - 284. [Abstract] [Full Text] [PDF]

				M. A. Vargas, M. St-Louis, L. Desgroseillers, J.-L. Charli, and G. Boileau Parathyroid Hormone-Related Protein(1-34) Regulates Phex Expression in Osteoblasts through the Protein Kinase A Pathway Endocrinology, November 1, 2003; 144(11): 4876 - 4885. [Abstract] [Full Text] [PDF]

				S. G. Dubois, A. F. Ruchon, A. Delalandre, G. Boileau, and D. Lajeunesse Role of abnormal neutral endopeptidase-like activities in Hyp mouse bone cells in renal phosphate transport Am J Physiol Cell Physiol, November 1, 2002; 283(5): C1414 - C1421. [Abstract] [Full Text] [PDF]

				E. R. Hines, J. F. Collins, M. D. Jones, S. H. Serey, and F. K. Ghishan Glucocorticoid regulation of the murine PHEX gene Am J Physiol Renal Physiol, August 1, 2002; 283(2): F356 - F363. [Abstract] [Full Text] [PDF]

				S. Liu, R. Guo, and L. D. Quarles Cloning and Characterization of the Proximal Murine Phex Promoter Endocrinology, September 1, 2001; 142(9): 3987 - 3995. [Abstract] [Full Text] [PDF]

				P S N ROWE The molecular background to hypophosphataemic rickets Arch. Dis. Child., September 1, 2000; 83(3): 192 - 194. [Full Text] [PDF]